ghk-cu clinical trials side effects Effects: What Does the Research Say? Doctor Explains 5 GHK Cu Peptide Injection

Havent noticed any weight loss

You must seek medical attention and contact your practitioner if you develop any signs or symptoms of skin infection around the injection site

Watch out for these red flags to avoid low-quality peptides

The Phase 2 trial enrolled participants with obesity and evaluated multiple dose levels over 48 weeks: 1 mg dose: 8.7% average body weight reduction 4 mg dose (escalated from 2 mg): 17.1% average body weight reduction 8 mg dose (escalated from 2 mg): 22.8% average body weight reduction 12 mg dose (escalated from 2 mg): 24.2% average body weight reduction Placebo: 2.1% average body weight reduction Those Phase 2 numbers were striking enough